Veterinary and Comparative Oncology

Veterinary and Comparative Oncology, A decade in cancer research
pp. 1-1(1)
Author: Argyle, David

Growth hormone receptor (<i>ghr</i>) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line
pp. 2-15(14)
Authors: Pawłowski, K. M.; Popielarz, D.; Szyszko, K.; Gajewska, M.; Motyl, T.; Król, M.

Radiotherapy in the management of localized mucocutaneous oral lymphoma in dogs: 14 cases
pp. 16-23(8)
Authors: Berlato, D.; Schrempp, D.; Van Den Steen, N.; Murphy, S.

Radiotherapy-induced myelosuppression in dogs: 103 cases (2002-2006)
pp. 24-32(9)
Authors: Clermont, T.; LeBlanc, A. K.; Adams, W. H.; LeBlanc, C. J.; Bartges, J. W.

Outcome in dogs with surgically resected oral fibrosarcoma (1997-2008)^*
pp. 33-43(11)
Authors: Frazier, S. A.; Johns, S. M.; Ortega, J.; Zwingenberger, A. L.; Kent, M. S.; Hammond, G. M.; Rodriguez, C. O.; Steffey, M. A.; Skorupski, K. A.

Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cells
pp. 44-56(13)
Authors: Hafeman, S. D.; Varland, D.; Dow, S. W.

Outcome of 19 dogs with parathyroid carcinoma after surgical excision^*
pp. 57-64(8)
Authors: Sawyer, E. S.; Northrup, N. C.; Schmiedt, C. W.; Culp, W. T. N.; Rassnick, K. M.; Garrett, L. D.; Selting, K. A.; Saba, C. F.; Howerth, E. W.

Clinical outcome in 94 cases of dermal haemangiosarcoma in dogs treated with surgical excision: 1993-2007*
pp. 65-73(9)
Authors: Szivek, A.; Burns, R. E.; Gericota, B.; Affolter, V. K.; Kent, M. S.; Rodriguez, C. O.; Skorupski, K. A.

Expression of PDGFR-<i>β</i> and Kit in canine anal sac apocrine gland adenocarcinoma using tissue immunohistochemistry
pp. 74-79(6)
Authors: Brown, R. J.; Newman, S. J.; Durtschi, D. C.; LeBlanc, A. K.